This study aimed to evaluate if clinical outcomes of MG after thymoma resection were associated with the presence of ectopic ...

In recent years, research into cancer survival has increasingly focused on prognostic factors that can accurately predict patient outcomes and tailor treatment approaches. Among these, systemic ...

MRD status before allo-HSCT is a strong prognostic factor for OS, DFS, and CIR in AML and MDS patients. MRD-negative patients showed significantly better OS and DFS compared to MRD-positive patients, ...

Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is ...

Metastatic kidney survival rates don’t predict individual outcomes. A number of factors, including overall health, tumor characteristics, and response to treatment, influence prognosis and survival.

Of the 491 patients, 21.2% had HER2-low expression, 30% had HER2 overexpression, and 50% had HER2-negative expression. Among the hormone receptor (HR)–positive patients, 34% had HER2-low expression; ...

Patients with connective tissue disease-associated PAH have 1-, 3-, and 5-year survival rates similar to those with idiopathic PAH. Contemporary patients with connective tissue disease-associated ...

A new study in The American Journal of Pathology suggests that perilipin 2 could serve as a prognostic factor and points to new potential lipid-based targets for treating lung adenocarcinoma. This ...

A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

A patient walks into a thoracic surgery consultation with a small lung tumor, stage I on every scan, and every conventional ...